These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22292378)

  • 1. [Pharmacovigilance of major parmaceutical innovation].
    Xiang Y; Xie Y; Yi D
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2831-5. PubMed ID: 22292378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Case study of Chinese medicine after listing of pharmacovigilance].
    Xiang Y; Xie Y; Yi D
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2836-9. PubMed ID: 22292379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Necessity of applying pharmacovigilance in post-marketing safety monitoring of traditional Chinese medicine injections].
    Wang HN; Chen W; Fu Z; Du WM; He J
    Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):612-4. PubMed ID: 18536393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Explore method about post-marketing safety re-evaluation of Chinese patent medicines based on HIS database in real world].
    Yang W; Xie Y; Zhuang Y
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2779-82. PubMed ID: 22292363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacovigilance data mining with methods based on false discovery rates: a comparative simulation study.
    Ahmed I; Thiessard F; Miremont-Salamé G; Bégaud B; Tubert-Bitter P
    Clin Pharmacol Ther; 2010 Oct; 88(4):492-8. PubMed ID: 20811349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A qualitative approach to signal mining in pharmacovigilance using formal concept analysis.
    Lillo-Le Louët A; Toussaint Y; Villerd J
    Stud Health Technol Inform; 2010; 160(Pt 2):969-73. PubMed ID: 20841828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacovigilance in Traditional Chinese Medicine safety surveillance.
    Wang H; Ye X; Gao Q; Wu C; Qian Y; Luo B; Sun Y; He J
    Pharmacoepidemiol Drug Saf; 2009 May; 18(5):357-61. PubMed ID: 19253921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sample size calculation in clinical post-marketing evaluation of traditional Chinese medicine].
    Fu Y; Xie Y
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2904-6. PubMed ID: 22292397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal detection of methylphenidate by comparing a spontaneous reporting database with a claims database.
    Kim J; Kim M; Ha JH; Jang J; Hwang M; Lee BK; Chung MW; Yoo TM; Kim MJ
    Regul Toxicol Pharmacol; 2011 Nov; 61(2):154-60. PubMed ID: 21510997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Construction and realization of real world integrated data warehouse from HIS on re-evaluation of post-maketing traditional Chinese medicine].
    Zhuang Y; Xie B; Weng S; Xie Y
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2883-7. PubMed ID: 22292392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the MedDRA hierarchy on pharmacovigilance data mining results.
    Pearson RK; Hauben M; Goldsmith DI; Gould AL; Madigan D; O'Hara DJ; Reisinger SJ; Hochberg AM
    Int J Med Inform; 2009 Dec; 78(12):e97-e103. PubMed ID: 19230751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Designs and thoughts of real world integrated data warehouse from HIS on re-evaluation of post-maketing traditional Chinese medicine].
    Zhuang Y; Xie B; Weng S; Xie Y
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2880-2. PubMed ID: 22292391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated support for pharmacovigilance: a proposed system.
    Bright RA; Nelson RC
    Pharmacoepidemiol Drug Saf; 2002 Mar; 11(2):121-5. PubMed ID: 11998536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacovigilance systems and databases in Korea, Japan, and Taiwan.
    Kimura T; Matsushita Y; Yang YH; Choi NK; Park BJ
    Pharmacoepidemiol Drug Saf; 2011 Dec; 20(12):1237-45. PubMed ID: 21936017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?
    Trifirò G; Pariente A; Coloma PM; Kors JA; Polimeni G; Miremont-Salamé G; Catania MA; Salvo F; David A; Moore N; Caputi AP; Sturkenboom M; Molokhia M; Hippisley-Cox J; Acedo CD; van der Lei J; Fourrier-Reglat A;
    Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1176-84. PubMed ID: 19757412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thought on several problems of post-marketing herbs clinical evaluation in special populations].
    Zhou A; Lian F
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2776-8. PubMed ID: 22292362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Discussion on development of four diagnostic information scale for clinical re-evaluation of postmarketing herbs].
    He W; Xie Y; Wang Y
    Zhongguo Zhong Yao Za Zhi; 2011 Dec; 36(24):3548-50. PubMed ID: 22368876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reports of hyperkalemia after publication of RALES--a pharmacovigilance study.
    Hauben M; Reich L; Gerrits CM
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):775-83. PubMed ID: 16804951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of computer-aided disproportionality analysis for post-marketing signal detection.
    Lehman HP; Chen J; Gould AL; Kassekert R; Beninger PR; Carney R; Goldberg M; Goss MA; Kidos K; Sharrar RG; Shields K; Sweet A; Wiholm BE; Honig PK
    Clin Pharmacol Ther; 2007 Aug; 82(2):173-80. PubMed ID: 17507922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research about re-evaluation of screening of traditonal Chinese medicine symptoms item of post-marketing medicine Xuezhikang].
    He W; Xie Y; Wang Y
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2898-900. PubMed ID: 22292395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.